Cardiovascular Disease Risk in Women Surviving Breast Cancer: Insights from the National Health Interview Survey (2019–2022) - Report - MDSpire

Cardiovascular Disease Risk in Women Surviving Breast Cancer: Insights from the National Health Interview Survey (2019–2022)

  • By

  • Robina Josiah Willock

  • Samah R. Nabi

  • Daniel C. Parks

  • Brye A. Qaseem

  • Miriam A. Miles

  • April 14, 2026

  • 0 min

Share

Cardiovascular Disease Risk in Women Surviving Breast Cancer: Insights from the National Health Interview Survey (2019–2022)

Overview

This study highlights the significant risk of cardiovascular disease (CVD) among women who are breast cancer survivors, particularly those who have survived for 10 years or more. Key factors associated with increased CVD risk include sociodemographic characteristics, lifestyle behaviors, and clinical comorbidities.

Background

Breast cancer is a prevalent cancer among women in the United States, and its survivors face an elevated risk of cardiovascular disease, which is a leading cause of morbidity and mortality. Understanding the interplay between breast cancer survivorship and cardiovascular health is crucial for developing effective prevention and management strategies.

Data Highlights

Survivorship DurationCVD Prevalence
10+ yearsHighest
1-5 yearsLeast

Key Findings

  • CVD prevalence is highest among women surviving breast cancer for 10 years or more.
  • Factors significantly associated with CVD include being unmarried, delayed medical care, hypertension, smoking history, poor general health, and older age.
  • Preventive behaviors and management of comorbidities are essential for reducing CVD risk in breast cancer survivors.
  • Clinical guidelines recommend lifelong CVD screening for breast cancer survivors, particularly those with a history of certain treatments.
  • Racial and ethnic disparities exist in both breast cancer and cardiovascular disease outcomes.

Clinical Implications

Healthcare providers should implement lifelong cardiovascular screening and risk assessment for breast cancer survivors, particularly focusing on those with significant risk factors. A holistic approach to managing cardiovascular health should be prioritized throughout the survivorship trajectory.

Conclusion

The findings underscore the importance of continuous cardiovascular risk assessment and management in breast cancer survivors to mitigate long-term health complications.

Related Resources & Content

  1. The ASCO Post, 2023 -- Cardiovascular Health of Women Treated for Cancer: Understanding the Long-Term Risks
  2. The ASCO Post, 2017 -- New Data on Prognostic Factors, Disease Detection, Drug Toxicities, and Treatment Adherence Presented at SABCS
  3. The ASCO Post, 2022 -- How Do Lifestyle and Cardiovascular Risk Factors Relate to Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors?
  4. Recommended Reading - ESC Council of Cardio-Oncology -- Cardio-Oncology
  5. Medscape -- Can Heart Drug Prevent Cardiotoxicity in Breast Cancer Care?
  6. PubMed -- Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors
  7. The ASCO Post — New Data on Prognostic Factors, Disease Detection, Drug Toxicities, and Treatment Adherence Presented at SABCS
  8. Recommended Reading - ESC Council of Cardio-Oncology
  9. Can Heart Drug Prevent Cardiotoxicity in Breast Cancer Care?
  10. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors - PubMed

Original Source(s)

Related Content